Loading clinical trials...
Loading clinical trials...
Dynamic FDG-PET in Aggressive Lymphoma and Pancreas Cancer
To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease aggressiveness and prognosis, for optimized tailoring of the therapeutic strategy in the individual patient.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Rambam Medical Center
Haifa, Israel
Start Date
August 1, 2006
Primary Completion Date
September 1, 2009
Completion Date
April 1, 2010
Last Updated
July 29, 2010
70
ESTIMATED participants
PET-CT
DEVICE
Lead Sponsor
Rambam Health Care Campus
NCT05053971
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions